fbpx Skip to main content

Member's Profile

SillaJen Biotherapeutics, Inc.

475 Sansome St Ste 740
San Francisco,   California
United States
Membership Info
Membership Type: Industry
Membership Since: 2016
Need to make an update to your Member Profile or have a question? Contact us here: [email protected]
About SillaJen Biotherapeutics, Inc.
Biotech Company
SillaJen, Inc. is a South Korean based biotechnology company headquartered in Busan South Korea, with satellite offices in Seoul, South Korea and San Francisco, CA. The company is focused on the development and commercialization of oncolytic immunotherapy products using the SOLVEâ„¢ platform, including its lead product Pexa-Vec, which is currently in Phase 3 trials for the treatment of advanced primary liver cancer.
Related News
No related news posted by this Member